The U.S. Food and Drug Administration (FDA) on Aug. 22 approved new COVID-19 vaccines from Moderna and Pfizer-BioNTech.
The shots, based on messenger ribonucleic acid technology (mRNA), target the KP.2 strain.
FDA Approves New COVID-19 Vaccines
Regulators said that waning protection from the previous vaccines prompted the move.
The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
